Break it Down: Optiscan progresses real-time telepathology platform to minimum viable product stage
Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.
In this episode, host Tylah Tully looks at the latest from Optiscan (ASX:OIL), who have progressed its cloud-based telepathology streaming software project to minimum viable product stage.
Watch the video to find out the latest.
While Opitscan is a Stockhead advertiser, it did not sponsor this content.
Related Topics

UNLOCK INSIGHTS
Discover the untold stories of emerging ASX stocks.
Daily news and expert analysis, it's free to subscribe.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.